Gastric/ Stomach Cancer

Overview

Approximately 25,000 cases of stomach cancer are diagnosed each year in the United States. There are many potential risk factors for stomach cancer, which can include: tobacco use, dietary factors (e.g. high intake of nitroso compounds), helicobacter pylori bacterial infection, and genetic predisposition. Diagnosis of gastric cancer is typically made by a biopsy, done during an upper endoscopic examination of the esophagus. Once a diagnosis of gastric cancer is established, imaging studies are often performed to help determine the cancer stage.

Treatment Options

Determination of the appropriate treatment for gastric cancer may require evaluation by a surgeon and/or medical oncologist and/or other specialists. Consultation with an oncologist is often needed, to help coordinate an appropriate treatment plan. Treatment options includes surgery, radiation neoadjuant or perioperative chemotherapy, chemoradiation, or chemotherapy alone for metastatic disease. Chemotherapy agents used include 5-FU, cisplatin, oxaliplatin, irinotecan, antracyclines, and taxanes.

Gastric/ Stomach Cancer

Raymond Tsao, MD

Dr. Raymond Tsao

Dr. Tsao is board certified in medical oncology and hematology. He is currently seeing patients with all types of cancer, with a focus on hematologic and gastrointestinal malignancies, including esophageal, stomach, colorectal and pancreatic cancer. Dr. Tsao is a member of the American Society of Clinical Oncology and American Society of Hematology.

Click here to learn more about Dr. Raymond Tsao.

Dr. Vijay Narendran

Dr. Vijay Narendran

Dr. Narendran is board certified in medical oncology and hematology. Dr. Narendran treats a variety of cancers and has a special interest in gastrointestinal and hematologic malignancies. Dr. Narendran is a member of the American Society of Clinical Oncology and the American Society of Hematology.

Click here to learn more about Dr. Vijay Narendran.

Share This